Free Trial

AbbVie (ABBV) SEC Filings & 10K Form

AbbVie logo
$211.27 +2.24 (+1.07%)
Closing price 03/3/2025 03:59 PM Eastern
Extended Trading
$211.28 +0.00 (+0.00%)
As of 07:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent AbbVie SEC Filings

DateFilerForm TypeView
02/28/2025
4:37 PM
AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:00 PM
AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:00 PM
AbbVie (Issuer)
Buckbee Kevin K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:47 PM
AbbVie (Subject)
Buckbee Kevin K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
4:00 PM
AbbVie (Filer)
Form 424B5
02/19/2025
8:22 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
8:25 PM
AbbVie (Subject)
Form FWP
02/18/2025
7:41 AM
AbbVie (Filer)
Form 424B5
02/14/2025
12:17 PM
AbbVie (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
6:30 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2025
6:42 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:31 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
4:00 PM
AbbVie (Issuer)
Buckbee Kevin K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:34 PM
AbbVie (Subject)
Buckbee Kevin K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
3:15 PM
AbbVie (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/04/2024
3:16 PM
AbbVie (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/04/2024
1:19 PM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
6:43 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:07 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
4:00 PM
AbbVie (Issuer)
Quaggin Susan E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:00 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:00 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:00 PM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:06 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
2:30 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
4:40 PM
AbbVie (Subject)
Hudson Thomas J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:22 PM
AbbVie (Subject)
Hudson Thomas J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
2:00 PM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
9:54 AM
AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
6:41 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:40 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:17 PM
AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
1:07 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:00 PM
AbbVie (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/03/2024
10:28 AM
AbbVie (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
05/17/2024
8:03 AM
AbbVie (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
05/07/2024
7:16 PM
AbbVie (Issuer)
Davis Jennifer L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:30 PM
AbbVie (Issuer)
WADDELL FREDERICK H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:30 PM
AbbVie (Issuer)
TILTON GLENN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:30 PM
AbbVie (Issuer)
BURNSIDE WILLIAM H.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:30 PM
AbbVie (Issuer)
Roberts Rebecca B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Three new patents reveal Elon and Trump’s secret “Project America” (Ad)

Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR! He says these 5 stocks are trading for less than $2 right now… But they could soon SOAR in Trump’s first 100 days.

Get the names and tickers now for $1
05/07/2024
5:30 PM
AbbVie (Issuer)
MEYER MELODY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:30 PM
AbbVie (Issuer)
Hart Brett J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:30 PM
AbbVie (Issuer)
AUSTIN ROXANNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:30 PM
AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:30 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:30 PM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
5:31 PM
AbbVie (Issuer)
Quaggin Susan E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
10:04 AM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
6:43 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
4:00 PM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
4:00 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
4:00 PM
AbbVie (Issuer)
Quaggin Susan E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
1:31 PM
AbbVie (Subject)
Chevedden John (Filed by)
Form PX14A6G
03/22/2024
4:00 PM
AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
1:29 PM
AbbVie (Subject)
Donoghoe Nicholas (Reporting)
Form 144/A
03/20/2024
6:30 PM
AbbVie (Subject)
Donoghoe Nicholas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
4:00 PM
AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:27 PM
AbbVie (Filer)
Form ARS
03/05/2024
4:30 PM
AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ABBV) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners